Compile Data Set for Download or QSAR
Report error Found 49 Enz. Inhib. hit(s) with all data for entry = 50030439
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296224(1-(4-(3-morpholinopropoxy)phenyl)-3-(4-(trifluorom...)
Affinity DataIC50: 0.800nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296210(1-Adamantan-1-yl-3-[4-fluoro-3-(3-morpholin-4-yl-p...)
Affinity DataIC50: 0.800nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296223(1-(4-(3-morpholinopropoxy)phenyl)-3-(4-(trifluorom...)
Affinity DataIC50: 0.800nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296214(1-(4-fluoro-3-(3-morpholinopropoxy)phenyl)-3-(4-(t...)
Affinity DataIC50: 0.800nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50276625(1-Adamantan-1-yl-3-[3-(3-morpholin-4-yl-propoxy)-p...)
Affinity DataIC50: 0.800nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50276673(1-(3-(3-morpholinopropoxy)phenyl)-3-(4-(trifluorom...)
Affinity DataIC50: 1nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296213(1-(4-fluoro-3-(3-morpholinopropoxy)phenyl)-3-(4-(t...)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296226(2-Adamantan-1-yl-N-[4-(3-morpholin-4-yl-propoxy)-p...)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50223389(1-adamantan-1-yl-3-[4-(3-morpholin-4-yl-propoxy)ph...)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296225(1-(4-chlorophenyl)-3-(4-(3-morpholinopropoxy)pheny...)
Affinity DataIC50: 1.5nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296197(1-(4-chlorophenyl)-3-(3-(3-morpholinopropoxy)pheny...)
Affinity DataIC50: 2nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50276676(2-Adamantan-1-yl-N-[3-(3-morpholin-4-yl-propoxy)-p...)
Affinity DataIC50: 2.5nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296219(1-Adamantan-1-yl-3-[3-(3-morpholin-4-yl-propoxy)-c...)
Affinity DataIC50: 2.5nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50276626(1-cyclohexyl-3-(3-(3-morpholinopropoxy)phenyl)urea...)
Affinity DataIC50: 3.90nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296215(1-(4-chlorophenyl)-3-(4-fluoro-3-(3-morpholinoprop...)
Affinity DataIC50: 4.80nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296220(2-Adamantan-1-yl-N-[3-(3-morpholin-4-yl-propoxy)-c...)
Affinity DataIC50: 5.20nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296221(1-cyclohexyl-3-(4-(3-morpholinopropoxy)phenyl)urea...)
Affinity DataIC50: 5.40nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296209(1-cyclohexyl-3-(4-fluoro-3-(3-morpholinopropoxy)ph...)
Affinity DataIC50: 6.5nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296216(2-Adamantan-1-yl-N-[4-fluoro-3-(3-morpholin-4-yl-p...)
Affinity DataIC50: 6.60nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50276674(1-(3-(3-morpholinopropoxy)phenyl)-3-(4-(trifluorom...)
Affinity DataIC50: 8nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296193(1-(3,4-difluorophenyl)-3-(3-(3-morpholinopropoxy)p...)
Affinity DataIC50: 11nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296196(1-(3-(3-morpholinopropoxy)phenyl)-3-(3-(trifluorom...)
Affinity DataIC50: 13.8nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296192(1-(4-fluorophenyl)-3-(3-(3-morpholinopropoxy)pheny...)
Affinity DataIC50: 14nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50276725(2-cyclohexyl-N-(3-(3-morpholinopropoxy)phenyl)acet...)
Affinity DataIC50: 28nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296199(1-(benzo[d][1,3]dioxol-5-yl)-3-(3-(3-morpholinopro...)
Affinity DataIC50: 33nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296191(1-(3-(3-morpholinopropoxy)phenyl)-3-phenylurea | C...)
Affinity DataIC50: 38nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296222(1-(4-(3-morpholinopropoxy)phenyl)-3-phenylurea | C...)
Affinity DataIC50: 39nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296212(1-(4-fluoro-3-(3-morpholinopropoxy)phenyl)-3-(4-fl...)
Affinity DataIC50: 40nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296229(N-(4-(3-morpholinopropoxy)phenyl)-2-(4-(trifluorom...)
Affinity DataIC50: 42nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296205(N-(3-(3-morpholinopropoxy)phenyl)-2-(4-(trifluorom...)
Affinity DataIC50: 43nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296228(N-(4-(3-morpholinopropoxy)phenyl)-2-(4-(trifluorom...)
Affinity DataIC50: 54nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50276727(N-(3-(3-morpholinopropoxy)phenyl)-2-(4-(trifluorom...)
Affinity DataIC50: 55nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296211(1-(4-fluoro-3-(3-morpholinopropoxy)phenyl)-3-pheny...)
Affinity DataIC50: 81nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296206(2-(4-chlorophenyl)-N-(3-(3-morpholinopropoxy)pheny...)
Affinity DataIC50: 116nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296194(1-(2,4-difluorophenyl)-3-(3-(3-morpholinopropoxy)p...)
Affinity DataIC50: 121nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296230(2-(4-chlorophenyl)-N-(4-(3-morpholinopropoxy)pheny...)
Affinity DataIC50: 140nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296218(N-(4-fluoro-3-(3-morpholinopropoxy)phenyl)-2-(4-(t...)
Affinity DataIC50: 145nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296217(N-(4-fluoro-3-(3-morpholinopropoxy)phenyl)-2-(4-(t...)
Affinity DataIC50: 156nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296200(1-(3-(dimethylamino)phenyl)-3-(3-(3-morpholinoprop...)
Affinity DataIC50: 240nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296204(2-(3,4-difluorophenyl)-N-(3-(3-morpholinopropoxy)p...)
Affinity DataIC50: 321nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296208(2-(benzo[d][1,3]dioxol-5-yl)-N-(3-(3-morpholinopro...)
Affinity DataIC50: 365nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296203(2-(4-fluorophenyl)-N-(3-(3-morpholinopropoxy)pheny...)
Affinity DataIC50: 550nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296227(N-(4-(3-morpholinopropoxy)phenyl)-2-phenylacetamid...)
Affinity DataIC50: 870nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296190(1-tert-butyl-3-(3-(3-morpholinopropoxy)phenyl)urea...)
Affinity DataIC50: 1.04E+3nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296202(3,3-dimethyl-N-(3-(3-morpholinopropoxy)phenyl)buta...)
Affinity DataIC50: 1.55E+3nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296195(1-(3-(3-morpholinopropoxy)phenyl)-3-(2,4,6-trifluo...)
Affinity DataIC50: 1.88E+3nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296201(1-(3-(3-morpholinopropoxy)phenyl)-3-(pyridin-3-yl)...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296198(1-(2,6-dichlorophenyl)-3-(3-(3-morpholinopropoxy)p...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed
TargetBifunctional epoxide hydrolase 2(Human)
Arete Therapeutics

Curated by ChEMBL
LigandPNGBDBM50296207(N-(3-(3-morpholinopropoxy)phenyl)-2-(pyridin-3-yl)...)
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibition of human soluble epoxide hydrolase by fluorescent endpoint assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2010
Entry Details Article
PubMed